These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15114043)

  • 1. Acupuncture and moxibustion in the treatment of active Crohn's disease: a randomized controlled study.
    Joos S; Brinkhaus B; Maluche C; Maupai N; Kohnen R; Kraehmer N; Hahn EG; Schuppan D
    Digestion; 2004; 69(3):131-9. PubMed ID: 15114043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acupuncture and moxibustion in the treatment of ulcerative colitis: a randomized controlled study.
    Joos S; Wildau N; Kohnen R; Szecsenyi J; Schuppan D; Willich SN; Hahn EG; Brinkhaus B
    Scand J Gastroenterol; 2006 Sep; 41(9):1056-63. PubMed ID: 16938719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial: moxibustion and acupuncture for the treatment of Crohn's disease.
    Bao CH; Zhao JM; Liu HR; Lu Y; Zhu YF; Shi Y; Weng ZJ; Feng H; Guan X; Li J; Chen WF; Wu LY; Jin XM; Dou CZ; Wu HG
    World J Gastroenterol; 2014 Aug; 20(31):11000-11. PubMed ID: 25152604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease.
    Dotan I; Rachmilewitz D; Schreiber S; Eliakim R; van der Woude CJ; Kornbluth A; Buchman AL; Bar-Meir S; Bokemeyer B; Goldin E; Maaser C; Mahadevan U; Seidler U; Hoffman JC; Homoky D; Plasse T; Powers B; Rutgeerts P; Hommes D;
    Gut; 2010 Jun; 59(6):760-6. PubMed ID: 20551461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sargramostim for active Crohn's disease.
    Korzenik JR; Dieckgraefe BK; Valentine JF; Hausman DF; Gilbert MJ;
    N Engl J Med; 2005 May; 352(21):2193-201. PubMed ID: 15917384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.
    Targan SR; Feagan BG; Fedorak RN; Lashner BA; Panaccione R; Present DH; Spehlmann ME; Rutgeerts PJ; Tulassay Z; Volfova M; Wolf DC; Hernandez C; Bornstein J; Sandborn WJ;
    Gastroenterology; 2007 May; 132(5):1672-83. PubMed ID: 17484865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moxibustion combined with acupuncture increases tight junction protein expression in Crohn's disease patients.
    Shang HX; Wang AQ; Bao CH; Wu HG; Chen WF; Wu LY; Ji R; Zhao JM; Shi Y
    World J Gastroenterol; 2015 Apr; 21(16):4986-96. PubMed ID: 25945013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators.
    Feagan BG; Rochon J; Fedorak RN; Irvine EJ; Wild G; Sutherland L; Steinhart AH; Greenberg GR; Gillies R; Hopkins M
    N Engl J Med; 1995 Feb; 332(5):292-7. PubMed ID: 7816064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy.
    Forbes GM; Sturm MJ; Leong RW; Sparrow MP; Segarajasingam D; Cummins AG; Phillips M; Herrmann RP
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):64-71. PubMed ID: 23872668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traditional acupuncture in migraine: a controlled, randomized study.
    Facco E; Liguori A; Petti F; Zanette G; Coluzzi F; De Nardin M; Mattia C
    Headache; 2008 Mar; 48(3):398-407. PubMed ID: 17868354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptom management for irritable bowel syndrome: a pilot randomized controlled trial of acupuncture/moxibustion.
    Anastasi JK; McMahon DJ; Kim GH
    Gastroenterol Nurs; 2009; 32(4):243-55. PubMed ID: 19696601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
    Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease.
    Thia KT; Sandborn WJ; Lewis JD; Loftus EV; Feagan BG; Steinhart AH; Hanauer SB; Persson T; Sands BE
    Am J Gastroenterol; 2008 Dec; 103(12):3123-31. PubMed ID: 18786111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natalizumab for active Crohn's disease.
    Ghosh S; Goldin E; Gordon FH; Malchow HA; Rask-Madsen J; Rutgeerts P; Vyhnálek P; Zádorová Z; Palmer T; Donoghue S;
    N Engl J Med; 2003 Jan; 348(1):24-32. PubMed ID: 12510039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Active Crohn's disease treated with acupuncture and moxibustion:a randomized controlled trial].
    Bao C; Wu L; Wu H; Liu H; Zhao J; Zeng X; Ma L; Li J; Zhao C; Wang S
    Zhongguo Zhen Jiu; 2016 Jul; 36(7):683-688. PubMed ID: 29231405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic effects of combined enteral nutrition with Tripterygium Wilfordii poly-glycoside in remission induction of active adult Crohn's disease].
    Gong JF; Niu LY; Wei XW; Zhu WM; Li N; Li JS
    Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(16):1213-7. PubMed ID: 19781164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of acupuncture and moxibustion to treat Bell's palsy according to different stages: design and protocol.
    Chen X; Li Y; Zheng H; Hu K; Zhang H; Zhao L; Li Y; Liu L; Mang L; Yu S
    Contemp Clin Trials; 2009 Jul; 30(4):347-53. PubMed ID: 19281871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease.
    Reinisch W; Hommes DW; Van Assche G; Colombel JF; Gendre JP; Oldenburg B; Teml A; Geboes K; Ding H; Zhang L; Tang M; Cheng M; van Deventer SJ; Rutgeerts P; Pearce T
    Gut; 2006 Aug; 55(8):1138-44. PubMed ID: 16492717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's disease.
    Sands BE; Katz S; Wolf DC; Feagan BG; Wang T; Gustofson LM; Wong C; Vandervoort MK; Hanauer S
    Gut; 2013 Sep; 62(9):1288-94. PubMed ID: 22760005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.
    Brandt J; Khariouzov A; Listing J; Haibel H; Sörensen H; Grassnickel L; Rudwaleit M; Sieper J; Braun J
    Arthritis Rheum; 2003 Jun; 48(6):1667-75. PubMed ID: 12794835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.